CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.83+0.05 (+6.00%)
Close on Nov 18, 2026Market cap $9.82MP/E –Yield –
CytoMed Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
CytoMed Therapeutics's market cap was $9.94M on Nov 11, 2026, against $21.23M a year earlier. Over the last 4 years it ranged from $9.31M to $41.38M, with a median of $24.33M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.94M | -35.5% |
| 2025 | Dec 31, 2025 | $15.41M | -60.7% |
| 2024 | Dec 31, 2024 | $39.20M | -5.3% |
| 2023 | Dec 29, 2023 | $41.38M | – |
See a number that looks wrong?